Tenet Healthcare (THC) has released an update to notify the public and investors about a regulation fd disclosure.
The Transaction is anticipated to yield a pretax gain of around $1.7 billion for the Company, which is expected to positively affect its income tax expense by about $150 million in 2024 due to decreased interest expense limitations. Additional details on the Transaction have been made public in a recent regulatory filing.
For further insights into THC stock, check out TipRanks’ Stock Analysis page.
For a comprehensive understanding of the announcement, you can read the full document here.
